In this episode, Peter L. Steinberg, MD, discusses a recent Urology Practice paper titled “Medical Malpractice and Nephrolithiasis: U.S. Appellate Cases From 2001- 2018,” for which he served as co-author. Steinberg is assistant professor of surgery at Harvard Medical School.

This episode's guest is Julia Beth Finkelstein, MD, MPH, CPPS. She discusses the recent Journal of Urology study “Telemedicine for Pediatric Urological Postoperative Care is Safe, Convenient and Economical,” for which she served as a study author. Finkelstein is assistant professor of urology at Columbia University Medical Center in New York.

For this episode, we bring you the third and final installment of Urology Times® Editorial Consultant Dr. J. Brantley Thrasher’s recent interview with Dr. Samuel J. Peretsman regarding high-intensity focused ultrasound. In this segment, Peretsman discusses robotic prostatectomy following HIFU and also explains how urologists can learn how to perform HIFU in their practice. Peretsman is with Urology Specialists of the Carolinas in Charlotte, North Carolina, and Thrasher is executive director of the American Board of Urology.

This episode features the second installment of Urology Times® Editorial Consultant Dr. J. Brantley Thrasher’s recent interview with Dr. Samuel J. Peretsman regarding high-intensity focused ultrasound. In the interview, Peretsman explains what he tells patients undergoing HIFU to expect postoperatively. Peretsman is with Urology Specialists of the Carolinas in Charlotte, North Carolina, and Thrasher is executive director of the American Board of Urology.

For this episode, Urology Times® Editorial Consultant Doctor J Brantley Thrasher interviews Doctor Samuel J. Peretsman regarding high-intensity focused ultrasound, or HIFU. Peretsman describes his background and experience with HIFU and also discusses his treatment criteria for the modality. Peretsman is with Urology Specialists of the Carolinas in Charlotte, North Carolina, and Thrasher is executive director of the American Board of Urology.

This is episode's guest is Dr. Angela B. Smith, Co-director of the Multidisciplinary Genitourinary Oncology Service at the N.C. Cancer Hospital; Director of Urologic Oncology in the UNC Department of Urology; and Associate Professor of Urology at UNC School of Medicine. A member of the study advisory committee for UroGen Pharma, Smith discusses the recent FDA approval of Jelmyto, which is the first therapy for the treatment of low-grade upper tract urothelial cancer.